Abstract:Objective To explore the potential mechanism by which hepatitis C virus (HCV) regulates hepatocellular carcinoma (HCC) cell quiescence through PCNA clamp associated factor (PCLAF).Methods The cell cycle distribution of HCC cell line HUH7 was detected after HCV infection. RNA-seq was performed on HCC cells infected with HCV or not, and the cell cycle distribution was detected following knockdown of differential genes using siRNA or overexpression of PCLAF. After overexpression of HCV nonstructural protein 5A (NS5A), the expression of PCLAF in and the cell cycle distribution of HCC cells were determined. The effect of HCV on the cell cycle distribution of HCC cells was observed after treatment with the PCLAF inhibitor α-hederin.Results After HCV infection, the percentages of HCC cells in the G0 phase and the G1 phase were decreased (P < 0.05), while those in the S phase and the G2/M phase were increased (P < 0.05). The percentage of HCC cells in the G0 phase was increased after knockdown of PCLAF (P < 0.05). In the case of HCV infection, the percentage of HCC cells in the G0 phase was decreased after overexpression of PCLAF (P < 0.05). Following overexpression of NS5A, the relative mRNA and protein expressions of PCLAF in HCC cells were increased (P < 0.05), the percentages of HCC cells in the G0 phase and the G1 phase were decreased (P < 0.05), and the percentages of HCC cells in the S phase and the G2/M phase were increased (P < 0.05). However, the cell cycle distribution was not significantly changed after overexpression of NS5A and knockdown of PCLAF. Combined overexpression of NS5A and treatment with α-hederin and combined HCV infection and treatment with α-hederin also did not alter the cell cycle distribution of HCC cells.Conclusions HCV induces HCC cells to skip the quiescence in the G0/G1 phase and to reduce the time for cell division. HCV NS5A protein inhibits HCC cell quiescence by increasing the expression of PCLAF, which could be blocked by the PCLAF inhibitor α-hederin.